One prior study [3] have shown that eEF2K activity plays a role in α-synuclein (AS) toxicity, and that inhibition of the eEF2K/eEF2 pathway is a potential target for reducing AS-induced oxidative stress in PD. The gene discussed is EEF2K; the disease is Parkinson disease.